A Cure is Within Our Grasp! It is amazing what happens when you change what doesn't work - Our Life Raft Group Research Team is a great example of this
MSKCC is launching a clinical trial that uses a MEK inhibitor to target ETV1 in combination with imatinib on a small group of newly diagnosed GIST patients
Clinical trials are a key step in the development and approval of new drugs to treat cancer and often a lifeline to patients seeking options when other treatments have failed.
Here are some photos from the GIST Day of Learning Chicago. Keep reading to check out the photos.
While there are many physical challenges that come with raising a child when you are living with GIST, Dana Pearson puts her energy into conquering the mental ones.
Adrian Mariño-Enriquez explains the significance of a recently published study that will have a big impact on GIST research. Keep reading to learn the critical role of CDC37 in GIST tumors.